[PDF][PDF] MYC promotes bone marrow stem cell dysfunction in Fanconi anemia

A Rodríguez, K Zhang, A Färkkilä, J Filiatrault, C Yang… - Cell stem cell, 2021 - cell.com
A Rodríguez, K Zhang, A Färkkilä, J Filiatrault, C Yang, M Velázquez, E Furutani…
Cell stem cell, 2021cell.com
Bone marrow failure (BMF) in Fanconi anemia (FA) patients results from dysfunctional
hematopoietic stem and progenitor cells (HSPCs). To identify determinants of BMF, we
performed single-cell transcriptome profiling of primary HSPCs from FA patients. In addition
to overexpression of p53 and TGF-β pathway genes, we identified high levels of MYC
expression. We correspondingly observed coexistence of distinct HSPC subpopulations
expressing high levels of TP53 or MYC in FA bone marrow (BM). Inhibiting MYC expression …
Summary
Bone marrow failure (BMF) in Fanconi anemia (FA) patients results from dysfunctional hematopoietic stem and progenitor cells (HSPCs). To identify determinants of BMF, we performed single-cell transcriptome profiling of primary HSPCs from FA patients. In addition to overexpression of p53 and TGF-β pathway genes, we identified high levels of MYC expression. We correspondingly observed coexistence of distinct HSPC subpopulations expressing high levels of TP53 or MYC in FA bone marrow (BM). Inhibiting MYC expression with the BET bromodomain inhibitor (+)-JQ1 reduced the clonogenic potential of FA patient HSPCs but rescued physiological and genotoxic stress in HSPCs from FA mice, showing that MYC promotes proliferation while increasing DNA damage. MYC-high HSPCs showed significant downregulation of cell adhesion genes, consistent with enhanced egress of FA HSPCs from bone marrow to peripheral blood. We speculate that MYC overexpression impairs HSPC function in FA patients and contributes to exhaustion in FA bone marrow.
cell.com